• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国湖北省艾滋病患者高效抗逆转录病毒治疗的效果评估

The effect evaluation of highly active antiretroviral therapy to patients with AIDS in Hubei province of China.

作者信息

Li Xuehua, Xu Yihua, Nie Shaofa, Xiang Hao, Wang Chongjian

机构信息

Department of Epidemiology and Statistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

出版信息

J Huazhong Univ Sci Technolog Med Sci. 2009 Oct;29(5):580-4. doi: 10.1007/s11596-009-0510-9. Epub 2009 Oct 11.

DOI:10.1007/s11596-009-0510-9
PMID:19821090
Abstract

The effects of highly active antiretroviral therapy (HAART) to patients with AIDS in Hubei province of China were investigated in order to provide scientific evidence to reinforce the management of HAART. Self-made questionnaires and descriptive method of epidemiology were used to collect and describe the changes of clinical symptoms, HIV RNA concentration, and immune function of patients with AIDS. After HAART, the effective rate of fever, cough, diarrhea, lymphadenectasis, weight loss, tetter, debility and fungous infection was 92.4%, 90.85%, 92.91%, 90.73%, 93.69%, 89.04%, 92.34%, and 83.1%, respectively. Of 117 patients with detected HIV RNA concentration, 41.03% had declined over 0.5 log, and 52.99% less than 0.5 log. CD4(+)T cell count was obviously increased: the average number after HAART for 3 or 6 months was 237/microL (26-755/microL) and 239/microL (17-833/microL), respectively. HAART can improve AIDS patients' clinical symptoms, reduce HIV RNA concentration, and maintain immune function. It is very important for the effectiveness of HAART to raise clinical adherence of patients with AIDS and have a persistent surveillance.

摘要

为了为加强高效抗逆转录病毒治疗(HAART)管理提供科学依据,对中国湖北省艾滋病患者接受HAART的效果进行了调查。采用自制问卷和流行病学描述方法,收集并描述艾滋病患者的临床症状、HIV RNA浓度及免疫功能变化。HAART治疗后,发热、咳嗽、腹泻、淋巴结肿大、体重减轻、皮疹、乏力及真菌感染的有效率分别为92.4%、90.85%、92.91%、90.73%、93.69%、89.04%、92.34%和83.1%。在117例检测HIV RNA浓度的患者中,41.03%下降超过0.5 log,52.99%下降小于0.5 log。CD4(+)T细胞计数明显增加:HAART治疗3个月和6个月后的平均数量分别为237/μL(26 - 755/μL)和239/μL(17 - 833/μL)。HAART可改善艾滋病患者的临床症状,降低HIV RNA浓度,并维持免疫功能。提高艾滋病患者的临床依从性并进行持续监测对HAART的有效性非常重要。

相似文献

1
The effect evaluation of highly active antiretroviral therapy to patients with AIDS in Hubei province of China.中国湖北省艾滋病患者高效抗逆转录病毒治疗的效果评估
J Huazhong Univ Sci Technolog Med Sci. 2009 Oct;29(5):580-4. doi: 10.1007/s11596-009-0510-9. Epub 2009 Oct 11.
2
Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.103例接受12个月高效抗逆转录病毒治疗的晚期艾滋病患者的临床结局和免疫重建
Chin Med J (Engl). 2006 Oct 20;119(20):1677-82.
3
[Study on the effect of treatment and the status of drug resistance among HIV/AIDS patients treated with highly active antiretroviral therapy in Shandong province].[山东省接受高效抗逆转录病毒治疗的HIV/AIDS患者治疗效果及耐药状况研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2007 Nov;28(11):1108-11.
4
The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.启动高效抗逆转录病毒治疗后女性CD4+细胞计数和HIV-1 RNA水平变化的预后重要性。
Ann Intern Med. 2004 Feb 17;140(4):256-64. doi: 10.7326/0003-4819-140-4-200402170-00007.
5
Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART.在接受长期高效抗逆转录病毒治疗(HAART)的艾滋病患者中,无论有无人类巨细胞病毒(HCMV)疾病,对HCMV的挽救性淋巴细胞增殖反应水平均呈下降趋势。
J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):320-31. doi: 10.1097/00126334-200112010-00003.
6
T-cell response of advanced aids patients after highly active antiretroviral therapy.高效抗逆转录病毒治疗后晚期艾滋病患者的T细胞反应
Chin Med Sci J. 2005 Dec;20(4):223-5.
7
[Study on the correlation between HIV drug resistance and CD4+ T-lymphocyte of AIDS patients under antiretroviral treatment in Henan province].[河南省接受抗逆转录病毒治疗的艾滋病患者HIV耐药性与CD4+T淋巴细胞相关性研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Dec;29(12):1181-4.
8
[The clinical outcome and immune reconstitution in 45 advanced AIDS patients undergoing highly active antiretroviral therapy for 12 months].45例晚期艾滋病患者接受高效抗逆转录病毒治疗12个月的临床结局及免疫重建
Zhonghua Nei Ke Za Zhi. 2006 Jul;45(7):569-72.
9
A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.一项关于在急性HIV感染期间启动联合抗逆转录病毒疗法潜在益处的多中心观察性研究。
J Infect Dis. 2006 Sep 15;194(6):725-33. doi: 10.1086/506616. Epub 2006 Aug 15.
10
Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.中国广西地区 HIV/AIDS 患者在接受高效抗逆转录病毒治疗(HAART)的第一年中,T 细胞亚群的动态变化及其与口腔和全身机会性感染的关系。
J Med Virol. 2015 Jul;87(7):1158-67. doi: 10.1002/jmv.24177. Epub 2015 Mar 16.

引用本文的文献

1
Rates and risk factors associated with the progression of HIV to AIDS among HIV patients from Zhejiang, China between 2008 and 2012.2008年至2012年间中国浙江HIV患者中HIV进展为AIDS的发生率及相关危险因素。
AIDS Res Ther. 2015 Sep 25;12:32. doi: 10.1186/s12981-015-0074-7. eCollection 2015.
2
Determinants of progression to AIDS and death following HIV diagnosis: a retrospective cohort study in Wuhan, China.HIV 诊断后进展为艾滋病和死亡的决定因素:中国武汉的一项回顾性队列研究。
PLoS One. 2013 Dec 23;8(12):e83078. doi: 10.1371/journal.pone.0083078. eCollection 2013.
3
Correlation analysis on total lymphocyte count and CD4 count in HIV-infected patients: a retrospective evaluation.

本文引用的文献

1
Predictors of CD4+ cell count response and of adverse outcome among HIV-infected patients receiving highly active antiretroviral therapy in a public hospital in Peru.秘鲁一家公立医院中接受高效抗逆转录病毒治疗的HIV感染患者的CD4+细胞计数反应及不良结局的预测因素
Int J Infect Dis. 2008 May;12(3):325-31. doi: 10.1016/j.ijid.2007.09.008.
2
HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals.来自初治和接受高效抗逆转录病毒治疗(HAART)个体的外周血淋巴细胞和单核细胞中的HIV-1 DNA载量分析。
J Infect. 2008 Mar;56(3):219-25. doi: 10.1016/j.jinf.2008.01.001. Epub 2008 Feb 13.
3
HIV感染患者总淋巴细胞计数与CD4计数的相关性分析:一项回顾性评估
J Huazhong Univ Sci Technolog Med Sci. 2011 Oct;31(5):712. doi: 10.1007/s11596-011-0588-8. Epub 2011 Oct 25.
Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohort.
阿巴卡韦、拉米夫定和齐多夫定用于初治HIV感染患者抗逆转录病毒治疗的有效性和安全性:一项大型多中心观察性队列研究结果
J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):154-9. doi: 10.1097/01.qai.0000194231.08207.8a.
4
Update on HAART in HIV.艾滋病高效抗逆转录病毒治疗进展
J Hepatol. 2006;44(1 Suppl):S100-3. doi: 10.1016/j.jhep.2005.11.021. Epub 2005 Nov 28.
5
Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy.
Clin Infect Dis. 2004 May 1;38(9):1311-6. doi: 10.1086/383572. Epub 2004 Apr 14.
6
Clinical, virologic, and immunologic response to efavirenz-or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study).在一组初治的晚期HIV感染患者中,对基于依非韦伦或蛋白酶抑制剂的高效抗逆转录病毒疗法的临床、病毒学和免疫学反应(EfaVIP 2研究)。
J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):343-50. doi: 10.1097/00126334-200404010-00003.
7
HIV transmission risk behavior and its relation to antiretroviral treatment adherence.
Sex Transm Dis. 2003 May;30(5):399-404. doi: 10.1097/00007435-200305000-00005.
8
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.开始高效抗逆转录病毒治疗的HIV-1感染患者的预后:前瞻性研究的协作分析
Lancet. 2002 Jul 13;360(9327):119-29. doi: 10.1016/s0140-6736(02)09411-4.
9
Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.HIV 感染患者对高效抗逆转录病毒疗法(HAART)的依从性:从预测性方法到动态方法。
Soc Sci Med. 2002 May;54(10):1481-96. doi: 10.1016/s0277-9536(01)00125-3.
10
Viral load trend in HIV-1 seropositive patients with different CD4 cell counts before starting HAART.开始高效抗逆转录病毒治疗(HAART)前,不同CD4细胞计数的HIV-1血清阳性患者的病毒载量趋势。
J Clin Virol. 2000 Jun;17(1):5-11. doi: 10.1016/s1386-6532(00)00064-0.